Search Results - "neuropsychiatric"

Refine Results
  1. 1
  2. 2
  3. 3

    Neuroprotective effects of Gypenosides: a review on preclinical studies in neuropsychiatric disorders by Liang, Gengfan, Lee, Yu Zhao, Siew, Audrey Foong Kow, Lee, Qi Long, Cheng Lim, Luis Wei, Yusof, Rohana, Tham, Chau Ling, Ho, Yu Cheng, Lee, Ming Tatt

    Published 2024
    “…To date, preclinical studies have demonstrated the therapeutic effects of gypenosides in alleviating neuropsychiatric disorders like depression, Parkinson’s disease, Alzheimer’s disease, secondary dementia, stroke, optic neuritis, etc. …”
    Get full text
    Get full text
  4. 4

    Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) – masquerade diagnosis: a case report by Mohd Hanafi, Mohd Sharil Iman, Che' Man, Mohamad, Che Alhadi, Shahidah

    Published 2019
    “…We highlighted a case of a man, lived with diagnosis of Schizophrenia for almost 15 years subsequently revealed him suffered from neuropsychiatric lupus as he fulfilled the SLE classification criteria. …”
    Get full text
    Get full text
  5. 5

    Neuropsychiatric systemic Lupus Erythematosus (NPSLE) – Masquerade diagnosis: A case report by Mohd Hanafi, Mohd Sharil Iman, Che' Man, Mohamad, Che Alhadi, Shahidah

    Published 2019
    “…Case report: We highlighted a case of a man, lived with diagnosis of Schizophrenia for almost 15 years subsequently revealed him suffered from neuropsychiatric lupus as he fulfilled the SLE classification criteria. …”
    Get full text
    Get full text
    Get full text
  6. 6

    Psychotropic polypharmacy in people with neuropsychiatric symptoms referred to an Australian dementia support service by Atee, Mustafa, Andreotta, Matthew, Morris, Thomas, Alford, Marie

    Published 2022
    “…Background: Despite limited evidence, psychotropics, such as antipsychotics are commonly used to treat neuropsychiatric symptoms (NPS) in people living with dementia. …”
    Get full text
  7. 7
  8. 8

    Neurodevelopmental and neuropsychiatric behaviour defects arise from 14-3-3ζ deficiency. by Cheah, Pike See, Ramshaw, H. S., Thomas, P. Q., Toyo-oka, K., Xu, X., Martin, S., Coyle, P., Guthridge, M. A., Stomski, F., Van den Buuse, M., Wynshaw-Boris, A., Lopez, A. F., Schwarz, Q. P.

    Published 2012
    “…Complex neuropsychiatric disorders are believed to arise from multiple synergistic deficiencies within connected biological networks controlling neuronal migration, axonal pathfinding and synapse formation. …”
    Get full text
    Get full text
  9. 9

    Relationship between neuropsychiatric symptoms and cognitive impairment in Parkinson's disease / Michelle Chan Su Ann by Michelle , Chan Su Ann

    Published 2017
    “…Patients with Parkinson’s Disease (PD) experience not only motor but also non-motor symptoms (NMSs). Neuropsychiatric symptoms (NPS) and cognitive impairment which are part of the NMSs, are prevalent among PD patients. …”
    Get full text
    Get full text
  10. 10
  11. 11

    Single nucleotide polymorphism of BDNF Val66Met (rs6265) and its association to neuropsychiatric disorders by Asraa Faris, Cheah, Pike See, Ling, King-Hwa

    Published 2020
    “…Concerning the past inconsistent reports, this mini-review aims at determining the association of BDNF rs6265 and neuropsychiatric disorders among the different studies. …”
    Get full text
  12. 12

    Delayed neuropsychiatric sequelae of carbon monoxide poisoning : a case report / Nurul Azreen Hashim … [et al.] by Hashim, Nurul Azreen, Shuib, Norley, Mohamed, Salina, Ling, Shiao Ling, Mat Nor, Khariah

    Published 2016
    “…Delayed neuropsychiatric sequelae is an important condition which commonly occur during recovery from acute carbon monoxide poisoning. …”
    Get full text
  13. 13
  14. 14

    Exploration of apathy in people living with neurocognitive disorder by Burgon, Clare

    Published 2023
    Subjects: “…apathy; dementia; mild cognitive impairment; neuropsychiatric symptoms; depression; daily functioning…”
    Get full text
  15. 15
  16. 16
  17. 17

    Factors Associated with Self and Informant Ratings of the Quality of Life of People with Dementia Living in Care Facilities: A Cross Sectional Study by Beer, C., Flicker, L., Horner, Barbara, Bretland, N., Scherer, S., Lautenschlager, N., Schaper, F., Almeida, O.

    Published 2010
    “…Cognitive impairment, case conferencing, hospitalizations and neuropsychiatric symptoms were found to be independently associated with staff rated ADRQL. …”
    Get full text
  18. 18

    Whole genome sequencing of 91 multiplex schizophrenia families reveals increased burden of rare, exonic copy number variation in schizophrenia probands and genetic heterogeneity by Khan, F., Melton, Phillip, McCarthy, N., Morar, B., Blangero, J., Moses, Eric, Jablensky, A.

    Published 2018
    “…We observe heterogeneity between families in terms of genes involved in CNVs, and find several CNVs involving genes previously implicated in either schizophrenia or other neuropsychiatric disorders.…”
    Get full text
  19. 19
  20. 20

    Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition by Bast, Tobias, Pezze, Marie, McGarrity, Stephanie

    Published 2017
    “…Both regions support important cognitive functions, including attention and memory, and their dysfunction has been implicated in cognitive deficits characterizing neuropsychiatric disorders. GABAergic inhibition shapes cortico-hippocampal neural activity and, recently, prefrontal and hippocampal neural disinhibition has emerged as a pathophysiological feature of major neuropsychiatric disorders, especially schizophrenia and age-related cognitive decline. …”
    Get full text